Rockefeller Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.1M Sell
537,734
-120,848
-18% -$8.34M 0.08% 232
2025
Q1
$45.7M Buy
658,582
+160,915
+32% +$11.2M 0.11% 180
2024
Q4
$42.9M Buy
497,667
+13,081
+3% +$1.13M 0.11% 181
2024
Q3
$57.7M Sell
484,586
-71,214
-13% -$8.48M 0.16% 142
2024
Q2
$79.3M Sell
555,800
-19,385
-3% -$2.77M 0.23% 100
2024
Q1
$73.9M Buy
575,185
+55,998
+11% +$7.19M 0.22% 110
2023
Q4
$53.7M Buy
519,187
+3,457
+0.7% +$358K 0.18% 130
2023
Q3
$46.9M Buy
515,730
+49,326
+11% +$4.49M 0.18% 132
2023
Q2
$37.7M Buy
466,404
+16,696
+4% +$1.35M 0.15% 162
2023
Q1
$35.8M Sell
449,708
-48,200
-10% -$3.84M 0.15% 152
2022
Q4
$33.7M Buy
497,908
+25,984
+6% +$1.76M 0.17% 139
2022
Q3
$23.5M Sell
471,924
-12,406
-3% -$618K 0.12% 182
2022
Q2
$27M Sell
484,330
-28,666
-6% -$1.6M 0.14% 157
2022
Q1
$28.5M Buy
512,996
+65,540
+15% +$3.64M 0.14% 167
2021
Q4
$25.1M Sell
447,456
-27,218
-6% -$1.52M 0.12% 189
2021
Q3
$22.8M Buy
474,674
+37,350
+9% +$1.79M 0.12% 192
2021
Q2
$18.3M Buy
437,324
+124,496
+40% +$5.21M 0.1% 219
2021
Q1
$10.5M Buy
312,828
+93,840
+43% +$3.16M 0.07% 244
2020
Q4
$7.65M Buy
218,988
+47,480
+28% +$1.66M 0.06% 253
2020
Q3
$5.95M Buy
171,508
+7,246
+4% +$252K 0.06% 245
2020
Q2
$5.38M Sell
164,262
-7,686
-4% -$252K 0.06% 237
2020
Q1
$5.18M Buy
171,948
+4,016
+2% +$121K 0.07% 216
2019
Q4
$4.86M Buy
167,932
+36,200
+27% +$1.05M 0.06% 224
2019
Q3
$3.41M Buy
131,732
+73,944
+128% +$1.91M 0.05% 229
2019
Q2
$1.48M Sell
57,788
-6,730
-10% -$172K 0.02% 292
2019
Q1
$1.69M Buy
64,518
+10,018
+18% +$262K 0.02% 289
2018
Q4
$1.26M Hold
54,500
0.02% 222
2018
Q3
$1.29M Sell
54,500
-1,000
-2% -$23.6K 0.02% 192
2018
Q2
$1.28M Hold
55,500
0.02% 196
2018
Q1
$1.37M Buy
+55,500
New +$1.37M 0.02% 194